NaveenPremnathMD

Oncology • Minneapolis, MN

Hematologic Oncology, Hospice & Palliative

Assistant Professor

Join to view full profile

Dr. Premnath is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Premnath's full profile

Already have an account?

Office
500 Harvard Street SE
Minneapolis, MN 55455

Education & Training

University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2020
University of Texas Southwestern Medical CenterFellowship, Hospice and Palliative Medicine, 2019 - 2020
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2016 - 2019
All India Institute of Medical SciencesClass of 2013

Certifications & Licensure

MN State Medical License 2023 - 2025
TX State Medical License 2020 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas.
Naveen Premnath, Yulun Liu, Heather Reves, Urvashi Pandey, Rasmi G Nair
JCO Oncology Practice. 2024-10-17
Racial and ethnic disparities in Acute Myeloid Leukemia: 15-year experience at a safety net hospital system.
Sharlene Dong, Naveen Premnath, Navid Sadeghi, Radhika Kainthla, Stephen S Chung
Leukemia Research. 2024-06-01
1 citations
Possible role of IL-23 inhibitor in autoimmune hemolytic anemia.
Naveen Premnath, Urvashi Pandey, Mohak Pandey, K Venuprasad
European Journal of Haematology. 2023-09-01

Journal Articles

BReast CAncer (BRCA) Gene Mutations as an Emerging Biomarker for the Treatment of Gastrointestinal Malignancies
Naveen Premnath, MD, Annals of Palliative Medicine
Assessment of Racial Differences in Rates of Autopsy in the US, 2008-2017
Naveen Premnath, MD, JAMA Internal Medicine

Abstracts/Posters

Burden and etiologies of 30-day readmission after bone marrow transplant: Insights from National Readmission Database.
Naveen Premnath, Karan Sud, Sathish Kumar Pondaiah, Arjun Gupta, Journal of Clinical Oncology, 5/20/2019
Analysis of Etiologies At 30 Day Re-Admissions Among Elderly and Young Adults
SK Pondaiah, K Sud, S Zajac, S Shah, LM-Y Chen, N Premnath, R Ernest Jean, American Thoracic Society 2019, 5/1/2019
Impact of Discharge Disposition on 30-day Readmissions Among Patients Admitted with Septic Shock
Karan Sud, Sathish Pondaiah, Naveen Premnath, Christian Olivo-Freites, Raymonde Jean, Critical Care Medicine, 1/1/2019
Septic Shock: Analysis of Etiologies at 30-day Readmissions
Sathish Pondaiah, Karan Sud, Naveen Premnath, Laura Chen, Ermias Jirru, Raymonde Jean, Critical Care Medicine, 1/1/2019
SPEAR: Study of Patients with Para-Pneumonic Pleural Effusion who are Re-Admitted within 30 days
Sathish Pondaiah, Karan Sud, Naveen Premnath, Karishma Bhatia, Adil Shujaat, Chest, 10/1/2018
Dissemination of information on neutropenic diet (ND) by top U.S. cancer centers: In line with evidence?
Dhruvika Mukhija, Naveen Premnath, Arjun Gupta, Anand Venkatraman, Sajan Jiv Singh Nagpal, Journal of Clinical Oncology, 5/20/2018
RETROSPECTIVE REVIEW OF EFFICACY AND DOSE INTENSITY OF SECONDLINE(SL) NAB-PACLITAXEL PLUS GEMCITABINE (NABG) FOR PATIENTS WITHMETASTATIC PANCREATIC ADENOCARCINOMA (MPA...
Shinoj Pattali, Jayakumar Sreenivasan, Naveen Premnath, Shannon Schmidt, Paul S Ritch, James P Thomas, Beth Erickson, Kathleen K Christians, SUsan Tsai, Douglas B Evan..., 50th annual meeting of Pancreas club, https://www.pancreasclub.com/wp-content/uploads/2017/10/PancreasClub_2016finalprogram.pdf, 5/20/2016
Join now to see all

Lectures

Burden and etiologies of 30-day readmission after bone marrow transplant: Insights from National Readmission Database.
2019 ASCO Annual Meeting - 6/1/2019